{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T22:27:11Z","timestamp":1794263231076,"version":"4.9.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"crossref","award":["No. 2024JDRC0042"],"award-info":[{"award-number":["No. 2024JDRC0042"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Health Commission of Sichuan Province Medical Science and Technology Program","award":["No. 24CXTD12"],"award-info":[{"award-number":["No. 24CXTD12"]}]},{"name":"Key science and technology program of Zigong","award":["No. 2024-YCY-01-02"],"award-info":[{"award-number":["No. 2024-YCY-01-02"]}]},{"name":"Major national science and technology projects","award":["No. 2024ZD0523505"],"award-info":[{"award-number":["No. 2024ZD0523505"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82401005"],"award-info":[{"award-number":["No. 82401005"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03298-5","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T12:07:29Z","timestamp":1761653249000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Metabolic dysfunction-associated fatty liver disease and the risk of gout: a UK Biobank prospective cohort study"],"prefix":"10.1186","volume":"30","author":[{"given":"Xin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-bin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghui","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-jia","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"issue":"3S","key":"3298_CR1","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1016\/j.semarthrit.2020.04.008","volume":"50","author":"JA Singh","year":"2020","unstructured":"Singh JA, Gaffo A. Gout epidemiology and comorbidities. Semin Arthritis Rheum. 2020;50(3S):S11\u20136. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.04.008.","journal-title":"Semin Arthritis Rheum"},{"issue":"10287","key":"3298_CR2","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1016\/S0140-6736(21)00569-9","volume":"397","author":"N Dalbeth","year":"2021","unstructured":"Dalbeth N, Gosling AL, Gaffo A, Abhishek A. Gout. Lancet Lond Engl. 2021;397(10287):1843\u201355. https:\/\/doi.org\/10.1016\/S0140-6736(21)00569-9.","journal-title":"Lancet Lond Engl"},{"key":"3298_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/bs.acc.2023.05.003","volume":"116","author":"W-Z Zhang","year":"2023","unstructured":"Zhang W-Z. Uric Acid En Route to Gout. Adv Clin Chem. 2023;116:209\u201375. https:\/\/doi.org\/10.1016\/bs.acc.2023.05.003.","journal-title":"Adv Clin Chem"},{"issue":"11","key":"3298_CR4","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1002\/art.41453","volume":"72","author":"A Danve","year":"2020","unstructured":"Danve A, Neogi T. Rising global burden of gout: time to act. Arthritis Rheumatol Hoboken NJ. 2020;72(11):1786\u20138. https:\/\/doi.org\/10.1002\/art.41453.","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"issue":"10","key":"3298_CR5","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s11926-017-0688-y","volume":"19","author":"GE Thottam","year":"2017","unstructured":"Thottam GE, Krasnokutsky S, Pillinger MH. Gout and metabolic syndrome: a tangled web. Curr Rheumatol Rep. 2017;19(10):60. https:\/\/doi.org\/10.1007\/s11926-017-0688-y.","journal-title":"Curr Rheumatol Rep"},{"issue":"12","key":"3298_CR6","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1016\/j.cgh.2021.12.002","volume":"20","author":"MH Le","year":"2022","unstructured":"Le MH, Yeo YH, Li X, Li J, Zou B, Wu Y, et al. 2019 Global NAFLD Prevalence: A Systematic Review and Meta-Analysis. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2022;20(12):2809-2817.e28. https:\/\/doi.org\/10.1016\/j.cgh.2021.12.002.","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"issue":"3","key":"3298_CR7","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3390\/gucdd1030014","volume":"1","author":"M Andr\u00e9s","year":"2023","unstructured":"Andr\u00e9s M. Gout and cardiovascular disease: mechanisms, risk estimations, and the impact of therapies. Gout Urate Cryst Depos Dis. 2023;1(3):152\u201366. https:\/\/doi.org\/10.3390\/gucdd1030014.","journal-title":"Gout Urate Cryst Depos Dis"},{"issue":"1","key":"3298_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/gucdd1010004","volume":"1","author":"T Bardin","year":"2023","unstructured":"Bardin T, Letavernier E, Correas J-M. The gouty kidney: a reappraisal. Gout Urate Cryst Depos Dis. 2023;1(1):25\u201336. https:\/\/doi.org\/10.3390\/gucdd1010004.","journal-title":"Gout Urate Cryst Depos Dis"},{"issue":"3","key":"3298_CR9","doi-asserted-by":"publisher","first-page":"e156","DOI":"10.1016\/S2665-9913(23)00338-7","volume":"6","author":"LD Ferguson","year":"2024","unstructured":"Ferguson LD, Molenberghs G, Verbeke G, Rahimi K, Rao S, McInnes IB, et al. Gout and incidence of 12 cardiovascular diseases: a case-control study including 152\u2008663 individuals with gout and 709\u2008981 matched controls. Lancet Rheumatol. 2024;6(3):e156\u201367. https:\/\/doi.org\/10.1016\/S2665-9913(23)00338-7.","journal-title":"Lancet Rheumatol"},{"issue":"2","key":"3298_CR10","doi-asserted-by":"publisher","first-page":"274","DOI":"10.12865\/CHSJ.50.02.13","volume":"50","author":"CD P\u00e2rv\u01cenescu","year":"2024","unstructured":"P\u00e2rv\u01cenescu CD, B\u01cerbulescu AL, Dinescu \u015eC, Bi\u021b\u01ce CE, Firulescu SC, Tra\u015fc\u01ce BA, et al. Subclinical atherosclerosis in a Gout cohort: prevalence and associations. Curr Health Sci J. 2024;50(2):274\u201382. https:\/\/doi.org\/10.12865\/CHSJ.50.02.13.","journal-title":"Curr Health Sci J"},{"issue":"6","key":"3298_CR11","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s11892-023-01506-2","volume":"23","author":"J Jiang","year":"2023","unstructured":"Jiang J, Zhang T, Liu Y, Chang Q, Zhao Y, Guo C, et al. Prevalence of diabetes in patients with hyperuricemia and gout: a systematic review and meta-analysis. Curr Diab Rep. 2023;23(6):103\u201317. https:\/\/doi.org\/10.1007\/s11892-023-01506-2.","journal-title":"Curr Diab Rep"},{"issue":"4","key":"3298_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12040605","volume":"12","author":"HG Choi","year":"2022","unstructured":"Choi HG, Kwon B-C, Kwon MJ, Kim JH, Kim J-H, Park B, et al. Association between gout and dyslipidemia: a nested case-control study using a national health screening cohort. J Pers Med. 2022;12(4):605. https:\/\/doi.org\/10.3390\/jpm12040605.","journal-title":"J Pers Med"},{"issue":"7","key":"3298_CR13","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1093\/rheumatology\/keaa773","volume":"60","author":"G Sandoval-Plata","year":"2021","unstructured":"Sandoval-Plata G, Nakafero G, Chakravorty M, Morgan K, Abhishek A. Association between serum urate, gout and comorbidities: a case-control study using data from the UK Biobank. Rheumatol Oxf Engl. 2021;60(7):3243\u201351. https:\/\/doi.org\/10.1093\/rheumatology\/keaa773.","journal-title":"Rheumatol Oxf Engl"},{"issue":"3","key":"3298_CR14","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","volume":"79","author":"VW-S Wong","year":"2023","unstructured":"Wong VW-S, Ekstedt M, Wong GL-H, Hagstr\u00f6m H. Changing epidemiology, global trends and implications for outcomes of NAFLD. J Hepatol. 2023;79(3):842\u201352. https:\/\/doi.org\/10.1016\/j.jhep.2023.04.036.","journal-title":"J Hepatol"},{"issue":"6","key":"3298_CR15","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","volume":"66","author":"LA Adams","year":"2017","unstructured":"Adams LA, Anstee QM, Tilg H, Targher G. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut. 2017;66(6):1138\u201353. https:\/\/doi.org\/10.1136\/gutjnl-2017-313884.","journal-title":"Gut"},{"issue":"9","key":"3298_CR16","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41575-021-00448-y","volume":"18","author":"G Targher","year":"2021","unstructured":"Targher G, Corey KE, Byrne CD, Roden M. The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments. Nat Rev Gastroenterol Hepatol. 2021;18(9):599\u2013612. https:\/\/doi.org\/10.1038\/s41575-021-00448-y.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"3298_CR17","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1136\/gutjnl-2021-324191","volume":"71","author":"A Mantovani","year":"2022","unstructured":"Mantovani A, Petracca G, Beatrice G, Csermely A, Tilg H, Byrne CD, et al. Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies. Gut. 2022;71(4):778\u201388. https:\/\/doi.org\/10.1136\/gutjnl-2021-324191.","journal-title":"Gut"},{"key":"3298_CR18","doi-asserted-by":"publisher","unstructured":"Bai JX, Shu RM, Huang Y, Peng Z. [Correlation between Serum Uric Acid and Risk of New-Onset Nonalcoholic Fatty Liver Disease: A 5-Year Observational Cohort Study]. Zhonghua Gan Zang Bing Za Zhi Zhonghua Ganzangbing Zazhi Chin J Hepatol. 2018;26(4):271\u201375. https:\/\/doi.org\/10.3760\/cma.j.issn.1007-3418.2018.04.008.","DOI":"10.3760\/cma.j.issn.1007-3418.2018.04.008"},{"issue":"8","key":"3298_CR19","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1590\/s0004-27302013000800006","volume":"57","author":"W Cai","year":"2013","unstructured":"Cai W, Wu X, Zhang B, Miao L, Sun Y-P, Zou Y, et al. Serum uric acid levels and non-alcoholic fatty liver disease in Uyghur and Han ethnic groups in Northwestern China. Arq Bras Endocrinol Metabol. 2013;57(8):617\u201322. https:\/\/doi.org\/10.1590\/s0004-27302013000800006.","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"3298_CR20","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.10691","volume":"9","author":"Y Hu","year":"2021","unstructured":"Hu Y, Li Q, Min R, Deng Y, Xu Y, Gao L. The association between serum uric acid and diabetic complications in patients with type 2 diabetes mellitus by gender: a cross-sectional study. PeerJ. 2021;9:e10691. https:\/\/doi.org\/10.7717\/peerj.10691.","journal-title":"PeerJ"},{"issue":"5","key":"3298_CR21","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.jhep.2008.11.021","volume":"50","author":"Y Li","year":"2009","unstructured":"Li Y, Xu C, Yu C, Xu L, Miao M. Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study. J Hepatol. 2009;50(5):1029\u201334. https:\/\/doi.org\/10.1016\/j.jhep.2008.11.021.","journal-title":"J Hepatol"},{"issue":"3","key":"3298_CR22","doi-asserted-by":"publisher","first-page":"378","DOI":"10.5009\/gnl.2010.4.3.378","volume":"4","author":"JW Lee","year":"2010","unstructured":"Lee JW, Cho YK, Ryan M, Kim H, Lee SW, Chang E, et al. Serum uric acid as a predictor for the development of nonalcoholic fatty liver disease in apparently healthy subjects: a 5-year retrospective cohort study. Gut Liver. 2010;4(3):378\u201383. https:\/\/doi.org\/10.5009\/gnl.2010.4.3.378.","journal-title":"Gut Liver"},{"issue":"6","key":"3298_CR23","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.metabol.2010.08.005","volume":"60","author":"S Ryu","year":"2011","unstructured":"Ryu S, Chang Y, Kim S-G, Cho J, Guallar E. Serum uric acid levels predict incident nonalcoholic fatty liver disease in healthy Korean men. Metabolism. 2011;60(6):860\u20136. https:\/\/doi.org\/10.1016\/j.metabol.2010.08.005.","journal-title":"Metabolism"},{"issue":"7","key":"3298_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011578","volume":"5","author":"C Xu","year":"2010","unstructured":"Xu C, Yu C, Xu L, Miao M, Li Y. High serum uric acid increases the risk for nonalcoholic fatty liver disease: a prospective observational study. PLoS ONE. 2010;5(7):e11578. https:\/\/doi.org\/10.1371\/journal.pone.0011578.","journal-title":"PLoS ONE"},{"issue":"8","key":"3298_CR25","doi-asserted-by":"publisher","first-page":"e3497","DOI":"10.1210\/clinem\/dgac190","volume":"107","author":"S Li","year":"2022","unstructured":"Li S, Fu Y, Liu Y, Zhang X, Li H, Tian L, et al. Serum uric acid levels and nonalcoholic fatty liver disease: a 2-sample bidirectional mendelian randomization study. J Clin Endocrinol Metab. 2022;107(8):e3497\u2013503. https:\/\/doi.org\/10.1210\/clinem\/dgac190.","journal-title":"J Clin Endocrinol Metab"},{"key":"3298_CR26","doi-asserted-by":"publisher","unstructured":"Bursill D, Taylor WJ, Terkeltaub R, Abhishek A, So AK, Vargas-Santos AB, Gaffo AL, Rosenthal A, Tausche A-K, Reginato A, Manger B, Scir\u00e9 C, Pineda C, van Durme C, Lin C-T, Yin C, Albert DA, Biernat-Kaluza E, Roddy E, Pascual E, Becce F, Perez-Ruiz F, Sivera F, Liot\u00e9 F, Schett G, Nuki G, Filippou G, McCarthy G, da Rocha Castelar Pinheiro G, Ea H-K, Tupinamb\u00e1 HAD, Yamanaka H, Choi HK, Mackay J, ODell JR, V\u00e1zquez Mellado J, Singh JA, Fitzgerald JD, Jacobsson LTH, Joosten L, Harrold LR, Stamp L, Andr\u00e9s M, Gutierrez M, Kuwabara M, Dehlin M, Janssen M, Doherty M, Hershfield MS, Pillinger M, Edwards NL, Schlesinger N, Kumar N, Slot O, Ottaviani S, Richette P, MacMullan PA, Chapman PT, Lipsky PE, Robinson P, Khanna PP, Gancheva RN, Grainger R, Johnson RJ, Te Kampe R, Keenan RT, Tedeschi SK, Kim S, Choi SJ, Fields TR, Bardin T, Uhlig T, Jansen T, Merriman T, Pascart T, Neogi T, Kl\u00fcck V, Louthrenoo W, Dalbeth NG. Hyperuricaemia and crystal-associated disease network (G-CAN) consensus statement regarding labels and definitions of disease states of gout. Ann Rheum Dis. 2019;78(11):1592\u20131600. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215933.","DOI":"10.1136\/annrheumdis-2019-215933"},{"key":"3298_CR27","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-230X-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, et al. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33. https:\/\/doi.org\/10.1186\/1471-230X-6-33.","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"3298_CR28","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.cgh.2020.11.028","volume":"20","author":"GS Jones","year":"2022","unstructured":"Jones GS, Alvarez CS, Graubard BI, McGlynn KA. Agreement between the prevalence of nonalcoholic fatty liver disease determined by transient elastography and fatty liver indices. Clin Gastroenterol Hepatol. 2022;20(1):227-229.e2. https:\/\/doi.org\/10.1016\/j.cgh.2020.11.028.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3298_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154955","volume":"127","author":"Z Liu","year":"2022","unstructured":"Liu Z, Lin C, Suo C, Zhao R, Jin L, Zhang T, et al. Metabolic dysfunction-associated fatty liver disease and the risk of 24 specific cancers. Metabolism. 2022;127:154955. https:\/\/doi.org\/10.1016\/j.metabol.2021.154955.","journal-title":"Metabolism"},{"issue":"1","key":"3298_CR30","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s12916-022-02460-8","volume":"20","author":"S Wu","year":"2022","unstructured":"Wu S, Yuan C, Yang Z, Liu S, Zhang Q, Zhang S, et al. Non-alcoholic fatty liver is associated with increased risk of irritable bowel syndrome: a prospective cohort study. BMC Med. 2022;20(1):262. https:\/\/doi.org\/10.1186\/s12916-022-02460-8.","journal-title":"BMC Med"},{"key":"3298_CR31","doi-asserted-by":"publisher","unstructured":"Wang ZY, Xia DD, Han GH. [Excerpt from the 2023 American association for the study of liver diseases practice guideline: prevention, diagnosis, and treatment of hepatocellular carcinoma]. Zhonghua Gan Zang Bing Za Zhi Zhonghua Ganzangbing Zazhi Chin J Hepatol. 2023;31(12):1262\u201365. https:\/\/doi.org\/10.3760\/cma.j.cn501113-20231107-00181.","DOI":"10.3760\/cma.j.cn501113-20231107-00181"},{"issue":"5","key":"3298_CR32","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/acr2.11252","volume":"3","author":"RK Topless","year":"2021","unstructured":"Topless RK, Phipps-Green A, Leask M, Dalbeth N, Stamp LK, Robinson PC, et al. Gout, rheumatoid arthritis, and the risk of death related to coronavirus disease 2019: an analysis of the UK biobank. ACR Open Rheumatol. 2021;3(5):333\u201340. https:\/\/doi.org\/10.1002\/acr2.11252.","journal-title":"ACR Open Rheumatol"},{"issue":"8","key":"3298_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0181260","volume":"12","author":"DJ Exeter","year":"2017","unstructured":"Exeter DJ, Zhao J, Crengle S, Lee A, Browne M. The New Zealand indices of multiple deprivation (IMD): a new suite of indicators for social and health research in Aotearoa, New Zealand. PLoS ONE. 2017;12(8):e0181260. https:\/\/doi.org\/10.1371\/journal.pone.0181260.","journal-title":"PLoS ONE"},{"issue":"5\u20136","key":"3298_CR34","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1242\/dmm.001180","volume":"2","author":"PL Huang","year":"2009","unstructured":"Huang PL. A comprehensive definition for metabolic syndrome. Dis Model Mech. 2009;2(5\u20136):231\u20137. https:\/\/doi.org\/10.1242\/dmm.001180.","journal-title":"Dis Model Mech"},{"issue":"6","key":"3298_CR35","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.14309\/ajg.0000000000002792","volume":"119","author":"X Dong","year":"2024","unstructured":"Dong X, Zhu Q, Yuan C, Wang Y, Ma X, Shi X, et al. Associations of intrapancreatic fat deposition with incident diseases of the exocrine and endocrine pancreas: a UK biobank prospective cohort study. Am J Gastroenterol. 2024;119(6):1158\u201366. https:\/\/doi.org\/10.14309\/ajg.0000000000002792.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"3298_CR36","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11906-018-0812-z","volume":"20","author":"MG Saklayen","year":"2018","unstructured":"Saklayen MG. The global epidemic of the metabolic syndrome. Curr Hypertens Rep. 2018;20(2):12. https:\/\/doi.org\/10.1007\/s11906-018-0812-z.","journal-title":"Curr Hypertens Rep"},{"key":"3298_CR37","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1741-7015-9-48","volume":"9","author":"E Kassi","year":"2011","unstructured":"Kassi E, Pervanidou P, Kaltsas G, Chrousos G. Metabolic syndrome: definitions and controversies. BMC Med. 2011;9:48. https:\/\/doi.org\/10.1186\/1741-7015-9-48.","journal-title":"BMC Med"},{"issue":"1","key":"3298_CR38","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13098-023-00997-z","volume":"15","author":"Z Liu","year":"2023","unstructured":"Liu Z, Wang Q, Huang H, Wang X, Xu C. Association between serum uric acid levels and long-term mortality of metabolic dysfunction-associated fatty liver disease: a nationwide cohort study. Diabetol Metab Syndr. 2023;15(1):27. https:\/\/doi.org\/10.1186\/s13098-023-00997-z.","journal-title":"Diabetol Metab Syndr"},{"issue":"6","key":"3298_CR39","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-048574","volume":"12","author":"J Wang","year":"2022","unstructured":"Wang J, Chen Y, Chen S, Wang X, Zhai H, Xu C. Prevalence and risk factors of hyperuricaemia in non-obese Chinese: a single-centre cross-sectional study. BMJ Open. 2022;12(6):e048574. https:\/\/doi.org\/10.1136\/bmjopen-2020-048574.","journal-title":"BMJ Open"},{"issue":"2","key":"3298_CR40","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1093\/aje\/kwr291","volume":"175","author":"S Ryu","year":"2012","unstructured":"Ryu S, Chang Y, Zhang Y, Kim S-G, Cho J, Son HJ, et al. A cohort study of hyperuricemia in middle-aged South Korean men. Am J Epidemiol. 2012;175(2):133\u201343. https:\/\/doi.org\/10.1093\/aje\/kwr291.","journal-title":"Am J Epidemiol"},{"issue":"6","key":"3298_CR41","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1016\/j.jhep.2015.01.019","volume":"62","author":"C Xu","year":"2015","unstructured":"Xu C, Wan X, Xu L, Weng H, Yan M, Miao M, et al. Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia: one stone hits two birds. J Hepatol. 2015;62(6):1412\u20139. https:\/\/doi.org\/10.1016\/j.jhep.2015.01.019.","journal-title":"J Hepatol"},{"issue":"5","key":"3298_CR42","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1111\/dom.15466","volume":"26","author":"Y Cho","year":"2024","unstructured":"Cho Y, Chang Y, Ryu S, Wild SH, Byrne CD. Baseline and change in serum uric acid level over time and resolution of nonalcoholic fatty liver disease in young adults: the Kangbuk Samsung health study. Diabetes Obes Metab. 2024;26(5):1644\u201357. https:\/\/doi.org\/10.1111\/dom.15466.","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"3298_CR43","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1097\/BOR.0b013e3283432d35","volume":"23","author":"H Yamanaka","year":"2011","unstructured":"Yamanaka H. Gout and hyperuricemia in young people. Curr Opin Rheumatol. 2011;23(2):156\u201360. https:\/\/doi.org\/10.1097\/BOR.0b013e3283432d35.","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"3298_CR44","doi-asserted-by":"publisher","first-page":"7378","DOI":"10.1038\/s41598-021-86962-0","volume":"11","author":"M Kurajoh","year":"2021","unstructured":"Kurajoh M, Fukumoto S, Yoshida S, Akari S, Murase T, Nakamura T, et al. Uric acid shown to contribute to increased oxidative stress level independent of xanthine oxidoreductase activity in MedCity21 Health Examination Registry. Sci Rep. 2021;11(1):7378. https:\/\/doi.org\/10.1038\/s41598-021-86962-0.","journal-title":"Sci Rep"},{"issue":"1","key":"3298_CR45","doi-asserted-by":"publisher","first-page":"7578","DOI":"10.1038\/s41598-020-64587-z","volume":"10","author":"E Zitt","year":"2020","unstructured":"Zitt E, Fischer A, Lhotta K, Concin H, Nagel G. Sex- and age-specific variations, temporal trends and metabolic determinants of serum uric acid concentrations in a large population-based Austrian cohort. Sci Rep. 2020;10(1):7578. https:\/\/doi.org\/10.1038\/s41598-020-64587-z.","journal-title":"Sci Rep"},{"issue":"2","key":"3298_CR46","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1080\/15257770.2010.551645","volume":"30","author":"Y Takiue","year":"2011","unstructured":"Takiue Y, Hosoyamada M, Kimura M, Saito H. The effect of female hormones upon urate transport systems in the mouse kidney. Nucleosides Nucleotides Nucleic Acids. 2011;30(2):113\u20139. https:\/\/doi.org\/10.1080\/15257770.2010.551645.","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"9","key":"3298_CR47","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1161\/HYPERTENSIONAHA.122.17956","volume":"79","author":"C Borghi","year":"2022","unstructured":"Borghi C, Agnoletti D, Cicero AFG, Lurbe E, Virdis A. Uric acid and hypertension: a review of evidence and future perspectives for the management of cardiovascular risk. Hypertension. 2022;79(9):1927\u201336. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.122.17956.","journal-title":"Hypertension"},{"key":"3298_CR48","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/5470739","volume":"2020","author":"X Li","year":"2020","unstructured":"Li X, Li L, Xing Y, Cheng T, Ren S, Ma H. Diabetes mellitus is associated with a lower risk of gout: a meta-analysis of observational studies. J Diabetes Res. 2020;2020:5470739. https:\/\/doi.org\/10.1155\/2020\/5470739.","journal-title":"J Diabetes Res"},{"issue":"1","key":"3298_CR49","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/dom.15310","volume":"26","author":"H Dai","year":"2024","unstructured":"Dai H, Hou T, Wang Q, Zhu Z, Zhu Y, Zhao Z, et al. The effect of Metformin on urate metabolism: findings from observational and Mendelian randomization analyses. Diabetes Obes Metab. 2024;26(1):242\u201350. https:\/\/doi.org\/10.1111\/dom.15310.","journal-title":"Diabetes Obes Metab"},{"issue":"10","key":"3298_CR50","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1136\/ard-2024-225652","volume":"83","author":"J Marrugo","year":"2024","unstructured":"Marrugo J, Santacroce LM, Paudel ML, Fukui S, Turchin A, Tedeschi SK, et al. Gout risk in adults with pre-diabetes initiating metformin. Ann Rheum Dis. 2024;83(10):1368\u201374. https:\/\/doi.org\/10.1136\/ard-2024-225652.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"3298_CR51","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.30885","volume":"6","author":"J Wei","year":"2023","unstructured":"Wei J, Choi HK, Dalbeth N, Li X, Li C, Zeng C, et al. Gout flares and mortality after sodium-glucose cotransporter-2 inhibitor treatment for gout and type 2 diabetes. JAMA Netw Open. 2023;6(8):e2330885. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.30885.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"3298_CR52","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/art.38918","volume":"67","author":"SC Kim","year":"2015","unstructured":"Kim SC, Liu J, Solomon DH. Risk of incident diabetes in patients with gout: a cohort study. Arthritis Rheumatol. 2015;67(1):273\u201380. https:\/\/doi.org\/10.1002\/art.38918.","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"3298_CR53","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1093\/rheumatology\/keg422","volume":"42","author":"S-Y Chen","year":"2003","unstructured":"Chen S-Y, Chen C-L, Shen M-L, Kamatani N. Trends in the Manifestations of Gout in Taiwan. Rheumatol Oxf Engl. 2003;42(12):1529\u201333. https:\/\/doi.org\/10.1093\/rheumatology\/keg422.","journal-title":"Rheumatol Oxf Engl"},{"issue":"1","key":"3298_CR54","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1186\/s12967-020-02590-8","volume":"18","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Zhang M, Yu X, Wei F, Chen C, Zhang K, et al. Association of hypertension and hypertriglyceridemia on incident hyperuricemia: an 8-year prospective cohort study. J Transl Med. 2020;18(1):409. https:\/\/doi.org\/10.1186\/s12967-020-02590-8.","journal-title":"J Transl Med"},{"key":"3298_CR55","doi-asserted-by":"publisher","unstructured":"Metabolomic profiling of plasma reveals potential biomarkers for screening and early diagnosis of gastric cancer and precancerous stages. Du 2023. MedComm Oncology Wiley Online Library. https:\/\/doi.org\/10.1002\/mog2.32. Accessed 16 Sept 2025","DOI":"10.1002\/mog2.32"},{"key":"3298_CR56","doi-asserted-by":"publisher","unstructured":"Fatty acids in cancer: Metabolic functions and potential treatment. Du 2023. MedComm Oncology Wiley Online Library. https:\/\/doi.org\/10.1002\/mog2.25. Accessed 16 Sept 2025","DOI":"10.1002\/mog2.25"},{"key":"3298_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101411","volume":"55","author":"Y Tanaka","year":"2022","unstructured":"Tanaka Y, Nagoshi T, Takahashi H, Oi Y, Yoshii A, Kimura H, et al. Urat1-selective inhibition ameliorates insulin resistance by attenuating diet-induced hepatic steatosis and brown adipose tissue whitening in mice. Mol Metab. 2022;55:101411. https:\/\/doi.org\/10.1016\/j.molmet.2021.101411.","journal-title":"Mol Metab"},{"key":"3298_CR58","doi-asserted-by":"publisher","unstructured":"Huang Y, Wan T, Hong Y, Wang X, Jiang X, Yang \u6768\u6d0b, Y, Gao H, Ji J, Wang L, Yang \u6768\u9633, Y, Li X, Wang H. Impact of NAFLD and fibrosis on adverse cardiovascular events in patients with hypertension. Hypertens Dallas Tex. 2025;82(6):1012\u201323. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.124.24252.","DOI":"10.1161\/HYPERTENSIONAHA.124.24252"},{"key":"3298_CR59","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ejim.2022.04.022","volume":"103","author":"S Copur","year":"2022","unstructured":"Copur S, Demiray A, Kanbay M. Uric acid in metabolic syndrome: does uric acid have a definitive role? Eur J Intern Med. 2022;103:4\u201312. https:\/\/doi.org\/10.1016\/j.ejim.2022.04.022.","journal-title":"Eur J Intern Med"},{"issue":"2","key":"3298_CR60","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41584-021-00725-9","volume":"18","author":"HK Choi","year":"2022","unstructured":"Choi HK, McCormick N, Yokose C. Excess comorbidities in gout: the causal paradigm and pleiotropic approaches to care. Nat Rev Rheumatol. 2022;18(2):97\u2013111. https:\/\/doi.org\/10.1038\/s41584-021-00725-9.","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"3298_CR61","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1097\/HJH.0000000000002359","volume":"38","author":"SP Juraschek","year":"2020","unstructured":"Juraschek SP, Simpson LM, Davis BR, Shmerling RH, Beach JL, Ishak A, et al. The effects of antihypertensive class on gout in older adults: secondary analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. J Hypertens. 2020;38(5):954\u201360. https:\/\/doi.org\/10.1097\/HJH.0000000000002359.","journal-title":"J Hypertens"},{"issue":"8","key":"3298_CR62","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s10654-024-01138-0","volume":"39","author":"L Wang","year":"2024","unstructured":"Wang L, Mesa-Eguiagaray I, Campbell H, Wilson JF, Vitart V, Li X, et al. A phenome-wide association and factorial Mendelian randomization study on the repurposing of uric acid-lowering drugs for cardiovascular outcomes. Eur J Epidemiol. 2024;39(8):869\u201380. https:\/\/doi.org\/10.1007\/s10654-024-01138-0.","journal-title":"Eur J Epidemiol"},{"issue":"5","key":"3298_CR63","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1002\/art.42381","volume":"75","author":"Y Eun","year":"2023","unstructured":"Eun Y, Han K, Lee SW, Kim K, Kang S, Lee S, et al. Altered risk of incident gout according to changes in metabolic syndrome status: a nationwide, population-based cohort study of 1.29 million young men. Arthritis Rheumatol Hoboken NJ. 2023;75(5):806\u201315. https:\/\/doi.org\/10.1002\/art.42381.","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"issue":"3","key":"3298_CR64","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/art.42996","volume":"77","author":"J Wei","year":"2025","unstructured":"Wei J, Wang Y, Dalbeth N, Xie J, Wu J, Zeng C, et al. Weight loss after receiving anti-obesity medications and gout among individuals with overweight and obese: a population-based cohort study. Arthritis Rheumatol Hoboken NJ. 2025;77(3):335\u201345. https:\/\/doi.org\/10.1002\/art.42996.","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"issue":"1","key":"3298_CR65","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41572-025-00599-1","volume":"11","author":"DQ Huang","year":"2025","unstructured":"Huang DQ, Wong VWS, Rinella ME, Boursier J, Lazarus JV, Yki-J\u00e4rvinen H, et al. Metabolic dysfunction-associated steatotic liver disease in adults. Nat Rev Dis Primer. 2025;11(1):14. https:\/\/doi.org\/10.1038\/s41572-025-00599-1.","journal-title":"Nat Rev Dis Primer"},{"key":"3298_CR66","unstructured":"Metabolomics in hyperuricemia and gout. https:\/\/www.mdpi.com\/2813-4583\/1\/1\/6. Accessed 16 Sept 2025"},{"issue":"2","key":"3298_CR67","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s12072-015-9682-5","volume":"10","author":"C Xu","year":"2016","unstructured":"Xu C. Hyperuricemia and nonalcoholic fatty liver disease: from bedside to bench and back. Hepatol Int. 2016;10(2):286\u201393. https:\/\/doi.org\/10.1007\/s12072-015-9682-5.","journal-title":"Hepatol Int"},{"key":"3298_CR68","unstructured":"Epigenetic and metabolic regulation of macrophages during gout. https:\/\/www.mdpi.com\/2813-4583\/1\/3\/13. Accessed 16 Sept 2025"},{"issue":"4","key":"3298_CR69","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.jhep.2015.11.022","volume":"64","author":"X Wan","year":"2016","unstructured":"Wan X, Xu C, Lin Y, Lu C, Li D, Sang J, et al. Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism. J Hepatol. 2016;64(4):925\u201332. https:\/\/doi.org\/10.1016\/j.jhep.2015.11.022.","journal-title":"J Hepatol"},{"issue":"48","key":"3298_CR70","doi-asserted-by":"publisher","first-page":"40732","DOI":"10.1074\/jbc.M112.399899","volume":"287","author":"MA Lanaspa","year":"2012","unstructured":"Lanaspa MA, Sanchez-Lozada LG, Choi Y-J, Cicerchi C, Kanbay M, Roncal-Jimenez CA, et al. Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver. J Biol Chem. 2012;287(48):40732\u201344. https:\/\/doi.org\/10.1074\/jbc.M112.399899.","journal-title":"J Biol Chem"},{"issue":"9","key":"3298_CR71","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1038\/s41431-021-00830-z","volume":"29","author":"RJ Reynolds","year":"2021","unstructured":"Reynolds RJ, Irvin MR, Bridges SL, Kim H, Merriman TR, Arnett DK, et al. Genetic correlations between traits associated with hyperuricemia, gout, and comorbidities. Eur J Hum Genet EJHG. 2021;29(9):1438\u201345. https:\/\/doi.org\/10.1038\/s41431-021-00830-z.","journal-title":"Eur J Hum Genet EJHG"},{"issue":"7","key":"3298_CR72","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1002\/art.42838","volume":"76","author":"H Qi","year":"2024","unstructured":"Qi H, Sun M, Terkeltaub R, Merriman TR, Chen H, Li Z, et al. Hyperuricemia subtypes classified according to renal uric acid handling manifesting distinct phenotypic and genetic profiles in people with gout. Arthritis Rheumatol Hoboken NJ. 2024;76(7):1130\u201340. https:\/\/doi.org\/10.1002\/art.42838.","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"issue":"1","key":"3298_CR73","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1186\/s12967-024-05408-z","volume":"22","author":"Y-J Kwon","year":"2024","unstructured":"Kwon Y-J, Choi J-E, Hong K-W, Lee J-W. Interplay of Mediterranean-diet adherence, genetic factors, and metabolic dysfunction-associated steatotic liver disease risk in Korea. J Transl Med. 2024;22(1):591. https:\/\/doi.org\/10.1186\/s12967-024-05408-z.","journal-title":"J Transl Med"},{"issue":"4","key":"3298_CR74","doi-asserted-by":"publisher","DOI":"10.1111\/liv.16124","volume":"45","author":"Y Seko","year":"2025","unstructured":"Seko Y, Yamaguchi K, Shima T, Iwaki M, Takahashi H, Kawanaka M, et al. Clinical utility of genetic variants in PNPLA3 and TM6SF2 to predict liver-related events in metabolic dysfunction-associated steatotic liver disease. Liver Int Off J Int Assoc Study Liver. 2025;45(4):e16124. https:\/\/doi.org\/10.1111\/liv.16124.","journal-title":"Liver Int Off J Int Assoc Study Liver"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03298-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03298-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03298-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:04:23Z","timestamp":1761696263000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-03298-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3298"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03298-5","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,28]]},"assertion":[{"value":"23 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"1027"}}